375 related articles for article (PubMed ID: 30588563)
1. Recent Developments in Male Contraception.
Thirumalai A; Page ST
Drugs; 2019 Jan; 79(1):11-20. PubMed ID: 30588563
[TBL] [Abstract][Full Text] [Related]
2. Androgens in male contraception.
Thirumalai A; Page ST
Best Pract Res Clin Endocrinol Metab; 2022 Sep; 36(5):101627. PubMed ID: 35249804
[TBL] [Abstract][Full Text] [Related]
3. The influence of pharmaceutical compounds on male fertility.
Neumann F; Diallo FA; Hasan SH; Schenck B; Traore I
Andrologia; 1976; 8(3):203-35. PubMed ID: 793446
[TBL] [Abstract][Full Text] [Related]
4. Hormonal Male Contraception: Getting to Market.
Page ST; Blithe D; Wang C
Front Endocrinol (Lausanne); 2022; 13():891589. PubMed ID: 35721718
[TBL] [Abstract][Full Text] [Related]
5. Hormonal male contraception: progress and prospects for the 21st century.
Handelsman DJ
Aust N Z J Med; 1995 Dec; 25(6):808-16. PubMed ID: 8770357
[TBL] [Abstract][Full Text] [Related]
6. Male hormonal contraception.
Cornia PB; Anawalt BD
Expert Opin Emerg Drugs; 2004 Nov; 9(2):335-44. PubMed ID: 15571489
[TBL] [Abstract][Full Text] [Related]
7. Male hormonal contraceptives: current status and future prospects.
Amory JK
Treat Endocrinol; 2005; 4(6):333-41. PubMed ID: 16318399
[TBL] [Abstract][Full Text] [Related]
8. The use of testosterone as a male contraceptive.
Amory JK; Bremner WJ
Baillieres Clin Endocrinol Metab; 1998 Oct; 12(3):471-84. PubMed ID: 10332567
[TBL] [Abstract][Full Text] [Related]
9. Male Hormonal Contraception.
Thirumalai A; Page ST
Annu Rev Med; 2020 Jan; 71():17-31. PubMed ID: 31537185
[TBL] [Abstract][Full Text] [Related]
10. The current state of male hormonal contraception.
Chao JH; Page ST
Pharmacol Ther; 2016 Jul; 163():109-17. PubMed ID: 27016468
[TBL] [Abstract][Full Text] [Related]
11. Hormonal approaches to male contraception.
Wang C; Swerdloff RS
Curr Opin Urol; 2010 Nov; 20(6):520-4. PubMed ID: 20808223
[TBL] [Abstract][Full Text] [Related]
12. Male contraception.
Wu FC
Baillieres Clin Obstet Gynaecol; 1996 Apr; 10(1):1-23. PubMed ID: 8736719
[TBL] [Abstract][Full Text] [Related]
13. Male hormonal contraceptives.
Anawalt BD; Amory JK
Expert Opin Pharmacother; 2001 Sep; 2(9):1389-98. PubMed ID: 11585019
[TBL] [Abstract][Full Text] [Related]
14. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone.
Anderson RA; Wallace AM; Wu FC
J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548
[TBL] [Abstract][Full Text] [Related]
15. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
[TBL] [Abstract][Full Text] [Related]
16. Would male hormonal contraceptives affect cardiovascular risk?
Zitzmann M
Asian J Androl; 2018; 20(2):145-148. PubMed ID: 29384141
[TBL] [Abstract][Full Text] [Related]
17. Drug insight: Recent advances in male hormonal contraception.
Amory JK; Page ST; Bremner WJ
Nat Clin Pract Endocrinol Metab; 2006 Jan; 2(1):32-41. PubMed ID: 16932251
[TBL] [Abstract][Full Text] [Related]
18. Testosterone/progestin regimens: a realistic option for male contraception?
Amory JK
Curr Opin Investig Drugs; 2004 Oct; 5(10):1025-30. PubMed ID: 15535423
[TBL] [Abstract][Full Text] [Related]
19. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
Behre HM; Nashan D; Hubert W; Nieschlag E
J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
[TBL] [Abstract][Full Text] [Related]
20. Target sites for suppressing fertility in the male.
Prasad MR; Rajalakshmi M
Adv Sex Horm Res; 1976; 2():263-87. PubMed ID: 797248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
